Biomedical Engineering Reference
In-Depth Information
3. Viswanathan CT, Bansal S, Booth B et al (2007) Quantitative bioanalytical methods validation
and implementation: best practices for chromatographic and ligand binding assays. AAPS J
9:E30-E42
4. Yu RZ, Baker B, Chappell A, Geary RS, Cheung E, Levin AA (2002) Development of an ultrasen-
sitive noncompetitive hybridization ligation enzyme-linked immunosorbent assay for the determi-
nation of phosphorothioate oligodeoxynucleotide in plasma. Anal Biochem 304(1):19-25
5. Deverre JR, Boutet V, Boquet D, Ezan E, Grassi J, Grognet JM (1997) A competitive enzyme
hybridization assay for plasma determination of phosphodiester and phosphorothioate anti-
sense oligonucleotides. Nucleic Acids Res 25(18):3584-3589
6. Deng P, Chen X, Zhang G, Zhong D (2010) Bioanalysis of an oligonucleotide and its metabo-
lites by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 52:571-579
7. Zhang G, Lin J, Srinivasan K, Kavetskaia O, Duncan JN (2007) Strategies for bioanalysis of
an oligonucleotide class macromolecule from rat plasma using liquid chromatography-tandem
mass spectrometry. Anal Chem 79(9):3416-3424
8. Li WK, Tse FL (2010) Dried blood spot sampling in combination with LC-MS/MS for quan-
titative analysis of small molecules. Biomed Chromatogr 24(1):49-65
9. Pan JW, Jiang XY, Chen YL (2010) Automatic supported liquid extraction (SLE) coupled with
HILIC-MS/MS: an application to method development and validation of erlotinib in human
plasma. Pharmaceutics 2:105-118
10. Wang J, Aubry A et al (2010) Effect of mobile phase pH, aqueous-organic ratio, and buffer
concentration on electrospray ionization tandem mass spectrometric fragmentation patterns:
implications in liquid chromatography/tandem mass spectrometric bioanalysis. Rapid Commun
Mass Spectrom 24:3221-3229
11. Meng M, Rohde L, Čápka V et al (2010) Fast chiral chromatographic method development and
validation for the quantitation of eszopiclone in human plasma using LC/MS/MS. J Pharma
Biomed Analy 53(4):973-982
12. Bennett PK, Meng M, Rohde L Software assisted chiral chromatographic method develop-
ment for the quantitation of four chiral drugs in human plasma using LC/MS/MS, Presented at
the 2009 ASMS conference, Philadelphia, PA
13. King R, Bonfiglio R, Fernandez-Metzler C et al (2000) Mechanistic investigation of ionization
suppression in electrospray ionization. J Am Soc Mass Spectrom 11(11):942-950
14. Ahnoff M, Wurzer A et al. (2003) Characterization of serum albumin and lysoPCs as major
contributors to plasma sample matrix effects on electrospray ionization efficiency, Presented
at the 2009 ASMS conference, Montreal, Canada
15. Bennett PK, Van Horne KC (2003) Identification of the major endogenous and persistent com-
pounds in plasma, serum, and tissue that cause matrix effects with electrospray LC/MS tech-
niques, Presented at the 2003 AAPS annual meeting and exposition, Salt Lake City, Utah
16. Xia YQ, Jemal M (2009) Phospholipids in liquid chromatography/mass spectrometry bio-
analysis: comparison of three tandem mass spectrometric techniques for monitoring plasma
phospholipids, the effect of mobile phase composition on phospholipids elution and the asso-
ciation of phospholipids with matrix effects. Rapid Commun Mass Spectrom 23:2125-2138
17. Meng M, Bennett PK Source for imprecision resulting from ionization suppression from
strongly retained phospholipids and dioctyl phthalate, Presented at 2004 ASMS conference,
Nashville, TN
18. Little JL, Wempe MF, Buchanan CM (2006) Liquid chromatography-mass spectrometry/mass
spectrometry method development for drug metabolism studies: examining lipid matrix ion-
ization effects in plasma. J Chromatogr B 833:219-230
19. Du L, White RL (2008) Reducing glycerophosphocholine lipid matrix interference effects in
biological fluid assays by using high-turbulence liquid chromatography. Rapid Commun Mass
Spectrom 22:3362-3370
20. Ismaiel OA, Halquist MS, Elmamly MY et al (2008) Monitoring phospholipids for assessment
of ion enhancement and ion suppression in ESI and APCI LC/MS/MS for chorpheniramine in
human plasma and the importance of multiple source matrix effect evaluation. J Chromatogr B
875:333-343
Search WWH ::




Custom Search